{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:01:24Z","timestamp":1785542484574,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s12350-015-0261-x","type":"journal-article","created":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T13:16:46Z","timestamp":1444396606000},"page":"1355-1363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis"],"prefix":"10.1016","volume":"23","author":[{"given":"Adam","family":"Casta\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"DeLuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Pozniakoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Blaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altaf","family":"Pirmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Bettencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Gollob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Karsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Vest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Codruta","family":"Chiuzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabahat","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-015-0261-x_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1532-5415.2011.03868.x","article-title":"Transthyretin cardiac amyloidoses in older North Americans","volume":"60","author":"Dharmarajan","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1007\/s12350-015-0261-x_bib2","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: Disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"10.1007\/s12350-015-0261-x_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","article-title":"Natural history and therapy of TTR-cardiac amyloidosis: Emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs","volume":"20","author":"Castano","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1007\/s12350-015-0261-x_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0002-8703(87)90703-4","article-title":"Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: A study with familial amyloid polyneuropathy","volume":"113","author":"Hongo","year":"1987","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-015-0261-x_bib5","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0002-8703(82)90331-3","article-title":"Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis","volume":"103","author":"Wizenberg","year":"1982","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-015-0261-x_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-015-0261-x_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovas Imaging"},{"key":"10.1007\/s12350-015-0261-x_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0735-1097(02)01944-7","article-title":"Myocardial contraction fraction: A volumetric index of myocardial shortening by freehand three-dimensional echocardiography","volume":"40","author":"King","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-015-0261-x_bib9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1191\/1740774504cn057oa","article-title":"The role of measurement reliability in clinical trials","volume":"1","author":"Lachin","year":"2004","journal-title":"Clin Trials"},{"key":"10.1007\/s12350-015-0261-x_bib10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nrcardio.2010.67","article-title":"Transthyretin-related amyloidoses and the heart: A clinical overview","volume":"7","author":"Rapezzi","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1007\/s12350-015-0261-x_bib11","unstructured":"Safety and efficacy of tafamidis in patients with transthyretin cardiomyopathy (ATTR-ACT); 2014. http:\/\/www.clnicaltrials.gov\/show\/NCT01994889.)"},{"key":"10.1007\/s12350-015-0261-x_bib12","unstructured":"Maurer M, JDP, Rosas GR, Mandel FS, Aarts J. Interim analysis of long-term, open-label tafamidis treatment in transthyretin amyloid cardiomyopathy after up to 5 years of treatment. In: International symposium on amyloidosis; 2014; Indianapolis, USA."},{"key":"10.1007\/s12350-015-0261-x_bib13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1007\/s12350-015-0261-x_bib14","unstructured":"Phase 2 study to evaluate ALN-TTRSC in patients with transthyretin (TTR) cardiac amyloidosis; 2014. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01981837.)"},{"key":"10.1007\/s12350-015-0261-x_bib15","unstructured":"Tolerability and efficacy of a combination of doxycycline and TUDCA in patients with transthyretin amyloid cardiomyopathy; 2013. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01855360?term=NCT01855360&rank=1"},{"key":"10.1007\/s12350-015-0261-x_bib16","unstructured":"Quarta CCF SR, Suhr SD, Obici OB, Perlini L, Lindqvist S, Koyama P, Sekijima J, Zeldenrust Y, Yamashita SR, Horibata T, Miller Y, Gorevic F, Merlini P, Ando G, Ikeda Y, Ruberg S, Berk F. The prevalence of cardiac amyloidosis in familial amyloidotic polyneuropathy with predominant neuropathy: The diflunisal trial. In: International Symposium on Amyloidosis; 2014; Indianapolis, USA. p. 88-9."},{"key":"10.1007\/s12350-015-0261-x_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1751-7133.2012.00303.x","article-title":"Diflunisal for ATTR cardiac amyloidosis","volume":"18","author":"Castano","year":"2012","journal-title":"Congest Heart Fail"},{"key":"10.1007\/s12350-015-0261-x_bib18","first-page":"284","article-title":"Binding of serum amyloid P-component (SAP) by amyloid fibrils","volume":"38","author":"Pepys","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"10.1007\/s12350-015-0261-x_bib19","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(88)92235-0","article-title":"Diagnostic radionuclide imaging of amyloid: Biological targeting by circulating human serum amyloid P component","volume":"1","author":"Hawkins","year":"1988","journal-title":"Lancet"},{"key":"10.1007\/s12350-015-0261-x_bib20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1699-0463.1994.tb04893.x","article-title":"Calcium-enhanced aggregation of serum amyloid P component and its inhibition by the ligands heparin and heparan sulphate. An electron microscopic and immunoelectrophoretic study","volume":"102","author":"Nielsen","year":"1994","journal-title":"APMIS"},{"key":"10.1007\/s12350-015-0261-x_bib21","doi-asserted-by":"crossref","first-page":"10392","DOI":"10.1074\/jbc.270.18.10392","article-title":"Ca(2+)-dependent binding of human serum amyloid P component to Alzheimer\u2019s beta-amyloid peptide","volume":"270","author":"Hamazaki","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1007\/s12350-015-0261-x_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00259-001-0730-0","article-title":"99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy","volume":"29","author":"Puille","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-015-0261-x_bib23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1529-8027.2012.00436.x","article-title":"Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset","volume":"17","author":"Russo","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"10.1007\/s12350-015-0261-x_bib24","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1007\/s00018-009-0109-0","article-title":"Transthyretin: the servant of many masters","volume":"66","author":"Buxbaum","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1007\/s12350-015-0261-x_bib25","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1073\/pnas.0400062101","article-title":"Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture","volume":"101","author":"Reixach","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s12350-015-0261-x_bib26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/978-94-007-5416-4_21","article-title":"Familial amyloidotic polyneuropathy and transthyretin","volume":"65","author":"Nagasaka","year":"2012","journal-title":"Sub-Cell Biochem"},{"issue":"Suppl 1","key":"10.1007\/s12350-015-0261-x_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/13506129.2012.668501","article-title":"Pathogenesis of transthyretin amyloidosis","volume":"19","author":"Benson","year":"2012","journal-title":"Amyloid"},{"key":"10.1007\/s12350-015-0261-x_bib28","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: A pilot study using (1)(8)F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-015-0261-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-015-0261-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123069805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123069805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-015-0261-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-015-0261-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:58:01Z","timestamp":1761026281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123069805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1071358123069805"],"URL":"https:\/\/doi.org\/10.1007\/s12350-015-0261-x","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-015-0261-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}